vs
FrontView REIT, Inc.（FVR）与TriSalus Life Sciences, Inc.（TLSI）财务数据对比。点击上方公司名可切换其他公司
FrontView REIT, Inc.的季度营收约是TriSalus Life Sciences, Inc.的1.4倍（$18.2M vs $13.2M），FrontView REIT, Inc.净利率更高（2.2% vs -73.9%，领先76.1%），TriSalus Life Sciences, Inc.同比增速更快（59.8% vs 12.0%）
TriSalus生命科学公司是一家临床阶段生物技术企业，专注于免疫肿瘤学与介入肿瘤学领域，研发专有的靶向给药技术，用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果，主要在北美市场开展临床合作及业务运营。
FVR vs TLSI — 直观对比
营收规模更大
FVR
是对方的1.4倍
$13.2M
营收增速更快
TLSI
高出47.9%
12.0%
净利率更高
FVR
高出76.1%
-73.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.2M | $13.2M |
| 净利润 | $400.0K | $-9.8M |
| 毛利率 | — | 86.7% |
| 营业利润率 | 24.9% | -24.8% |
| 净利率 | 2.2% | -73.9% |
| 营收同比 | 12.0% | 59.8% |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | — | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVRTLSI
| Q1 26 | $18.2M | — | ||
| Q4 25 | $16.5M | $13.2M | ||
| Q3 25 | $16.8M | $11.6M | ||
| Q2 25 | $17.6M | $11.2M | ||
| Q1 25 | $16.2M | $9.2M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | $14.5M | $7.3M | ||
| Q2 24 | — | $7.4M |
净利润FVRTLSI
| Q1 26 | $400.0K | — | ||
| Q4 25 | $-4.1M | $-9.8M | ||
| Q3 25 | $4.0M | $-10.8M | ||
| Q2 25 | $-2.9M | $-8.3M | ||
| Q1 25 | $-833.0K | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | $-2.4M | $-2.4M | ||
| Q2 24 | — | $-4.3M |
毛利率FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% |
营业利润率FVRTLSI
| Q1 26 | 24.9% | — | ||
| Q4 25 | — | -24.8% | ||
| Q3 25 | — | -77.9% | ||
| Q2 25 | — | -65.4% | ||
| Q1 25 | — | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | -118.9% | ||
| Q2 24 | — | -111.0% |
净利率FVRTLSI
| Q1 26 | 2.2% | — | ||
| Q4 25 | -24.9% | -73.9% | ||
| Q3 25 | 23.9% | -93.5% | ||
| Q2 25 | -16.5% | -73.9% | ||
| Q1 25 | -5.1% | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | -16.7% | -32.6% | ||
| Q2 24 | — | -58.8% |
每股收益（稀释后）FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | $-0.19 | $-0.22 | ||
| Q3 25 | $0.19 | $-0.96 | ||
| Q2 25 | $-0.16 | $-0.27 | ||
| Q1 25 | $-0.06 | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | — | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.3M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $514.2M | $-33.9M |
| 总资产 | $869.8M | $35.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVRTLSI
| Q1 26 | $9.3M | — | ||
| Q4 25 | $13.5M | $20.4M | ||
| Q3 25 | $19.6M | $22.7M | ||
| Q2 25 | $8.4M | $26.5M | ||
| Q1 25 | $3.3M | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $16.5M |
总债务FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | $314.3M | — | ||
| Q3 25 | $307.1M | — | ||
| Q2 25 | $316.9M | — | ||
| Q1 25 | $310.2M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FVRTLSI
| Q1 26 | $514.2M | — | ||
| Q4 25 | $391.2M | $-33.9M | ||
| Q3 25 | $385.2M | $-26.7M | ||
| Q2 25 | $369.9M | $-19.4M | ||
| Q1 25 | $324.7M | $-34.4M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | $1.0K | $-20.4M | ||
| Q2 24 | — | $-25.3M |
总资产FVRTLSI
| Q1 26 | $869.8M | — | ||
| Q4 25 | $854.4M | $35.3M | ||
| Q3 25 | $846.8M | $36.5M | ||
| Q2 25 | $856.5M | $41.3M | ||
| Q1 25 | $860.8M | $28.6M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | $1.0K | $27.5M | ||
| Q2 24 | — | $32.4M |
负债/权益比FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.80× | — | ||
| Q2 25 | 0.86× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | — | $-2.5M |
| 自由现金流率自由现金流/营收 | — | -19.1% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-19.1M |
8季度趋势，按日历期对齐
经营现金流FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | $42.1M | $-2.5M | ||
| Q3 25 | $8.3M | $-3.7M | ||
| Q2 25 | $9.3M | $-7.3M | ||
| Q1 25 | $8.1M | $-4.5M | ||
| Q4 24 | — | $-5.7M | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | — | $-13.4M |
自由现金流FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M |
自由现金流率FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% |
资本支出强度FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% |
现金转化率FVRTLSI
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
